Paul Bevan

3.0k total citations
76 papers, 2.0k citations indexed

About

Paul Bevan is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Cognitive Neuroscience. According to data from OpenAlex, Paul Bevan has authored 76 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Cellular and Molecular Neuroscience and 11 papers in Cognitive Neuroscience. Recurrent topics in Paul Bevan's work include Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Behavioral and Psychological Studies (9 papers). Paul Bevan is often cited by papers focused on Neuroscience and Neuropharmacology Research (15 papers), Neurotransmitter Receptor Influence on Behavior (10 papers) and Behavioral and Psychological Studies (9 papers). Paul Bevan collaborates with scholars based in United Kingdom, United States and Germany. Paul Bevan's co-authors include E. Szabadi, C. M. Bradshaw, Trevor Archer, A.R. Cools, C. Mala, Ian Shaw, Hamish Ryder, Arie S. Belldegrun, Peter Charlton and P. R. Saxena and has published in prestigious journals such as Journal of Clinical Oncology, Cancer Research and Brain Research.

In The Last Decade

Paul Bevan

73 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Paul Bevan United Kingdom 27 699 558 360 335 307 76 2.0k
Marie Bourgeois France 28 793 1.1× 504 0.9× 661 1.8× 159 0.5× 156 0.5× 119 3.2k
Mark Reimers United States 31 2.2k 3.1× 368 0.7× 379 1.1× 116 0.3× 878 2.9× 52 4.4k
Cordula Nitsch Germany 33 933 1.3× 1.5k 2.7× 431 1.2× 86 0.3× 122 0.4× 116 3.1k
M. Paola Castelli Italy 35 838 1.2× 1.3k 2.3× 318 0.9× 45 0.1× 186 0.6× 118 3.5k
David Goldstein United States 27 1.3k 1.8× 261 0.5× 110 0.3× 84 0.3× 120 0.4× 88 2.4k
William F. White United States 36 1.3k 1.9× 1.8k 3.2× 684 1.9× 67 0.2× 57 0.2× 169 4.4k
Susan L. Campbell United States 23 1.7k 2.4× 1.1k 2.0× 301 0.8× 71 0.2× 200 0.7× 47 3.3k
Olivier Delalande France 35 767 1.1× 949 1.7× 610 1.7× 128 0.4× 40 0.1× 134 4.0k
Barbara Schäuble Germany 23 458 0.7× 171 0.3× 271 0.8× 54 0.2× 176 0.6× 75 2.1k
Dawei Li China 23 767 1.1× 267 0.5× 218 0.6× 45 0.1× 217 0.7× 76 1.9k

Countries citing papers authored by Paul Bevan

Since Specialization
Citations

This map shows the geographic impact of Paul Bevan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Bevan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Bevan more than expected).

Fields of papers citing papers by Paul Bevan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Bevan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Bevan. The network helps show where Paul Bevan may publish in the future.

Co-authorship network of co-authors of Paul Bevan

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Bevan. A scholar is included among the top collaborators of Paul Bevan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Bevan. Paul Bevan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Middleton, Anna, Richard Milne, Heidi Howard, et al.. (2019). Members of the public in the USA, UK, Canada and Australia expressing genetic exceptionalism say they are more willing to donate genomic data. European Journal of Human Genetics. 28(4). 424–434. 24 indexed citations
2.
Milne, Richard, Katherine I. Morley, Heidi Howard, et al.. (2019). Trust in genomic data sharing among members of the general public in the UK, USA, Canada and Australia. Human Genetics. 138(11-12). 1237–1246. 65 indexed citations
3.
Middleton, Anna, Richard Milne, Adrian Thorogood, et al.. (2018). Attitudes of publics who are unwilling to donate DNA data for research. European Journal of Medical Genetics. 62(5). 316–323. 50 indexed citations
4.
Haagensen, Emma J., Huw D. Thomas, Wolfgang A. Schmalix, et al.. (2016). Enhanced anti-tumour activity of the combination of the novel MEK inhibitor WX-554 and the novel PI3K inhibitor WX-037. Cancer Chemotherapy and Pharmacology. 78(6). 1269–1281. 7 indexed citations
5.
Chamie, Karim, Paul Bevan, Stephan Störkel, et al.. (2015). Carbonic anhydrase-IX score is a novel biomarker that predicts recurrence and survival for high-risk, nonmetastatic renal cell carcinoma: Data from the phase III ARISER clinical trial. Urologic Oncology Seminars and Original Investigations. 33(5). 204.e25–204.e33. 31 indexed citations
6.
Zaťovičová, Miriam, Alžbeta Hulı́ková, Peter Ditte, et al.. (2014). Monoclonal antibody G250 targeting CA IX: Binding specificity, internalization and therapeutic effects in a non-renal cancer model. International Journal of Oncology. 45(6). 2455–2467. 33 indexed citations
7.
Belldegrun, Arie S., Karim Chamie, Paul Bevan, et al.. (2013). ARISER: A randomized double blind phase III study to evaluate adjuvant cG250 treatment versus placebo in patients with high-risk ccRCC—Results and implications for adjuvant clinical trials.. Journal of Clinical Oncology. 31(15_suppl). 4507–4507. 37 indexed citations
8.
9.
Mala, C., et al.. (2010). A phase I, first-in-human single ascending dose study of the MEK inhibitor WX-554 given to healthy male subjects.. Journal of Clinical Oncology. 28(15_suppl). e13666–e13666. 7 indexed citations
10.
Bevan, Paul & C. Mala. (2008). The Role of uPA and uPA Inhibitors in Breast Cancer. Breast Care. 3(2). 1–1. 9 indexed citations
11.
Penz, Thomas, et al.. (1996). Xenovulene A, a novel compound active at gaba, receptors: Functional studies on expressed recombinant and mammalian neuronal GABA(A) receptors. UCL Discovery (University College London). 1 indexed citations
12.
Sundaram, Hardy, et al.. (1996). Xenovulene A, a novel compound active at GABA(A) receptors: Characterisation by radioligand binding. UCL Discovery (University College London). 1 indexed citations
13.
Bevan, Paul, Hamish Ryder, & Ian Shaw. (1995). Identifying small-molecule lead compounds: The screening approach to drug discovery. Trends in biotechnology. 13(3). 115–121. 67 indexed citations
14.
Bevan, Paul, A.R. Cools, & Trevor Archer. (1989). Behavioural Pharmacology of 5-HT. Behavioural Pharmacology. 1(2). 188–188. 124 indexed citations
15.
Long, S.K., et al.. (1988). An in vitro mature spinal cord preparation from the rat. Neuropharmacology. 27(5). 541–546. 33 indexed citations
16.
Sloan, Philip, et al.. (1983). Adverse reactions during treatment with amiodarone hydrochloride. BMJ. 287(6392). 612.2–613. 2 indexed citations
17.
Bevan, Paul, C. M. Bradshaw, & E. Szabadi. (1976). Neuronal responses to adrenoceptor agonists in the cerebral cortex: evidence for excitatory alpha-adrenoceptors and inhibitory beta-adrenoceptors [proceedings].. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 58(3). 418P–418P. 2 indexed citations
18.
Bevan, Paul. (1975). Proceedings: The uptake of mescaline by rat brain synaptosomes.. PubMed. 54(2). 257P–258P. 1 indexed citations
19.
Bevan, Paul, C. M. Bradshaw, & M.H.T. Roberts. (1973). A simple low-cost circuit for the programmed application of ejecting and retaining currents in microelectrophoresis experiments.. PubMed. 48(2). 365P–366P. 3 indexed citations
20.
Bevan, Paul, C. M. Bradshaw, M.H.T. Roberts, & E. Szabadi. (1973). Proceedings: The dual action of tricyclic antidepressant drugs on responses of single cortical neurones to acetylcholine.. PubMed. 49(1). 173P–174P. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Marie Bourgeois Breakdown of academic impact, for papers by Mark Reimers Breakdown of academic impact, for papers by Cordula Nitsch Breakdown of academic impact, for papers by M. Paola Castelli Breakdown of academic impact, for papers by David Goldstein Breakdown of academic impact, for papers by William F. White Breakdown of academic impact, for papers by Susan L. Campbell Breakdown of academic impact, for papers by Olivier Delalande Breakdown of academic impact, for papers by Barbara Schäuble Breakdown of academic impact, for papers by Dawei Li
Rankless by CCL
2026